Nutriband Inc. Warrant
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.3828
- Today's High:
- $0.65
- Open Price:
- $0.6298
- 52W Low:
- $0.3828
- 52W High:
- $5.549
- Prev. Close:
- $0.638
- Volume:
- 8444
Company Statistics
- Market Cap.:
- $0
- Book Value:
- 1.151
- Revenue TTM:
- $1.39 million
- Operating Margin TTM:
- -217.71%
- Gross Profit TTM:
- $0
- Profit Margin:
- -225.7%
- Return on Assets TTM:
- -30.53%
- Return on Equity TTM:
- -72.7%
Company Profile
Nutriband Inc. Warrant had its IPO on 2021-10-01 under the ticker symbol NTRBW.
The company operates in the Healthcare sector and Biotechnology industry. Nutriband Inc. Warrant has a staff strength of 3 employees.
Stock update
Shares of Nutriband Inc. Warrant opened at $0.63 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.38 - $0.65, and closed at $0.47.
This is a -25.89% slip from the previous day's closing price.
A total volume of 8,444 shares were traded at the close of the day’s session.
In the last one week, shares of Nutriband Inc. Warrant have slipped by -30.47%.
Nutriband Inc. Warrant's Key Ratios
Nutriband Inc. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Nutriband Inc. Warrant’s revenue was $1.39 million with a gross profit of $0 and an EBITDA of $-2740005. The EBITDA ratio measures Nutriband Inc. Warrant's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Nutriband Inc. Warrant’s operating margin was -217.71% while its return on assets stood at -30.53% with a return of equity of -72.7%.
In Q1.3333333333333, Nutriband Inc. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 153.1%.
Nutriband Inc. Warrant’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.505 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nutriband Inc. Warrant’s profitability.
Nutriband Inc. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Nutriband Inc. Warrant stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $9.87 million
- Total Liabilities
- $874127.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $2624
- Dividend Payout Ratio
- 0%
Nutriband Inc. Warrant ended 2024 with $9.87 million in total assets and $0 in total liabilities. Its intangible assets were valued at $9.87 million while shareholder equity stood at $6.89 million.
Nutriband Inc. Warrant ended 2024 with $0 in deferred long-term liabilities, $874127.00 in other current liabilities, 7833.00 in common stock, $-24339107.00 in retained earnings and $5.02 million in goodwill. Its cash balance stood at $2.33 million and cash and short-term investments were $2.33 million. The company’s total short-term debt was $159,459 while long-term debt stood at $0.
Nutriband Inc. Warrant’s total current assets stands at $3.27 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $223452.00 compared to accounts payable of $0 and inventory worth $156921.00.
In 2024, Nutriband Inc. Warrant's operating cash flow was $0 while its capital expenditure stood at $2624.
Comparatively, Nutriband Inc. Warrant paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.47
- 52-Week High
- $5.549
- 52-Week Low
- $0.3828
- Analyst Target Price
- $
Nutriband Inc. Warrant stock is currently trading at $0.47 per share. It touched a 52-week high of $5.549 and a 52-week low of $5.549. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.98 and 200-day moving average was $2.07 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Nutriband Inc. Warrant
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.